Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Han MH, Hwang S-I, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald G H, Gerlitz B, Robinson WH, Baranzini SE, et al.